Header Logo

Diego Fernando Chamorro

TitlePostdoc Fellows and Associates
InstitutionBaylor College of Medicine
DepartmentPostDoc
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sotelo-Rodr?guez C, Vallejo-Ardila D, Ruiz-Pati?o A, Chamorro DF, Rodr?guez J, Moreno-P?rez DA, Carranza H, Otero J, Vargas C, Archila P, Rojas L, Zuluaga J, Rubio C, Ord??ez-Reyes C, Garcia-Robledo JE, Mej?a S, Jaller E, Arrieta O, Cardona AF. Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors. JCO Glob Oncol. 2024 Jan; 10:e2300011. PMID: 38237094; PMCID: PMC10805441.
      Citations:    Fields:    Translation:Humans
    2. Chamorro DF, Somes LK, Hoyos V. Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential. Cancers (Basel). 2023 Dec 26; 16(1). PMID: 38201551; PMCID: PMC10778447.
      Citations:    
    3. Chamorro DF, Cardona AF, Rodr?guez J, Ruiz-Pati?o A, Arrieta O, Moreno-P?rez DA, Rojas L, Zatarain-Barr?n ZL, Ardila DV, Viola L, Recondo G, Blaquier JB, Mart?n C, Raez L, Samtani S, Ord??ez-Reyes C, Garcia-Robledo JE, Corrales L, Sotelo C, Ricaurte L, Cuello M, Mej?a S, Jaller E, Vargas C, Carranza H, Otero J, Archila P, Bermudez M, Gamez T, Russo A, Malapelle U, de Miguel Perez D, de Lima VCC, Freitas H, Saldahna E, Rolfo C, Rosell R, CLICaP. Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study. Target Oncol. 2023 05; 18(3):425-440. PMID: 37017806; PMCID: PMC10192162.
      Citations:    
    4. Sussman L, Garcia-Robledo JE, Ord??ez-Reyes C, Forero Y, Mosquera AF, Ru?z-Pati?o A, Chamorro DF, Cardona AF. Integration of artificial intelligence and precision oncology in Latin America. Front Med Technol. 2022; 4:1007822. PMID: 36311461; PMCID: PMC9608820.
      Citations:    
    5. Raez LE, Arrieta O, Chamorro DF, Soberanis-Pi?a PD, Corrales L, Mart?n C, Cuello M, Samtani S, Recondo G, Mas L, Zatarain-Barr?n ZL, Ru?z-Pati?o A, Garc?a-Robledo JE, Ordo?ez-Reyes C, Jaller E, Dickson F, Rojas L, Rolfo C, Rosell R, Cardona AF. Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP). Front Oncol. 2022; 12:904800. PMID: 35903685; PMCID: PMC9321635.
      Citations:    
    6. Cordeiro de Lima VC, Corassa M, Saldanha E, Freitas H, Arrieta O, Raez L, Samtani S, Ramos M, Rojas C, Burotto M, Chamorro DF, Recondo G, Ruiz-Pati?o A, M?s L, Zatarain-Barr?n L, Mej?a S, Nicolas Minata J, Mart?n C, Bautista Blaquier J, Motta Guerrero R, Aliaga-Macha C, Carracedo C, Ord??ez-Reyes C, Garcia-Robledo JE, Corrales L, Sotelo C, Ricaurte L, Santoyo N, Cuello M, Jaller E, Rodr?guez J, Archila P, Bermudez M, Gamez T, Russo A, Viola L, Malapelle U, de Miguel Perez D, Rolfo C, Rosell R, Cardona AF. STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP). Lung Cancer. 2022 08; 170:114-121. PMID: 35753125.
      Citations:    
    7. Cardona AF, Mej?a SA, Viola L, Chamorro DF, Rojas L, Ru?z-Pati?o A, Serna A, Mart?nez S, Mu?oz ?, Rodr?guez J, Garc?a-Robledo JE, Pino LE, Zatarain-Barr?n ZL, Arrieta O. Lung Cancer in Colombia. J Thorac Oncol. 2022 08; 17(8):953-960. PMID: 35717323.
      Citations:    
    8. Ord??ez-Reyes C, Garcia-Robledo JE, Chamorro DF, Mosquera A, Sussmann L, Ruiz-Pati?o A, Arrieta O, Zatarain-Barr?n L, Rojas L, Russo A, de Miguel-Perez D, Rolfo C, Cardona AF. Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question. Pharmaceutics. 2022 Jun 11; 14(6). PMID: 35745815; PMCID: PMC9229626.
      Citations:    
    9. Cardona AF, Ruiz-Pati?o A, Recondo G, Mart?n C, Raez L, Samtani S, Minata JN, Blaquier JB, Enrico D, Burotto M, Ord??ez-Reyes C, Chamorro DF, Garcia-Robledo JE, Corrales L, Zatarain-Barr?n ZL, M?s L, Sotelo C, Ricaurte L, Santoyo N, Cuello M, Mej?a S, Jaller E, Vargas C, Carranza H, Otero J, Rodr?guez J, Archila P, Bermudez M, Gamez T, Cordeiro de Lima V, Freitas H, Russo A, Polo C, Malapelle U, Perez DM, Rolfo C, Viola L, Rosell R, Arrieta O. Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP). Clin Lung Cancer. 2022 09; 23(6):522-531. PMID: 35798634.
      Citations:    
    Chamorro's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (37)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _